The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $80.17

Today's change-1.04 -1.28%
Updated October 23 3:56 PM EDT. Delayed by at least 15 minutes.
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $80.17

Today's change-1.04 -1.28%
Updated October 23 3:56 PM EDT. Delayed by at least 15 minutes.

Gilead Sciences Inc crosses below 50-day moving average

Gilead Sciences Inc closed lower Monday, dropping (U.S.)$1.04 or 1.28% to (U.S.)$80.17 and crossing below its 50-day moving average. Over the last five days, shares have gained 0.28% and 11.95% year to date. Shares have underperformed the S&P 500 by 11.88% during the last year.

Key company metrics

  • Open(U.S.) $81.25
  • Previous close(U.S.) $81.21
  • High(U.S.) $81.32
  • Low(U.S.) $80.16
  • Bid / Ask(U.S.) $80.17 / (U.S.) $80.18
  • YTD % change+11.95%
  • Volume5,595,250
  • Average volume (10-day)7,528,141
  • Average volume (1-month)8,203,172
  • Average volume (3-month)9,550,680
  • 52-week range(U.S.) $63.76 to (U.S.) $86.27
  • Beta1.16
  • Trailing P/E8.70×
  • P/E 1 year forward9.26×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.08
  • Dividend yield2.59%
  • Trailing EPS(U.S.) $9.21
Updated October 23 3:56 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.03%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue7,1416,5057,3207,500
Total other revenue--------
Total revenue7,1416,5057,3207,500
Gross profit6,0155,5486,2456,371
Total cost of revenue1,1269571,0751,129
Total operating expense2,8872,7383,2753,101
Selling / general / administrative897850992831
Research & development8649311,2081,141
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income4,2543,7674,0454,399
Interest income (expense), net non-operating-269-261-265-242
Gain (loss) on sale of assets--------
Other--------
Income before tax4,1153,6173,9204,276
Income after tax3,0692,6993,0993,325
Income tax, total1,046918821951
Net income3,0732,7023,1083,330
Total adjustments to net income--------
Net income before extra. items3,0732,7023,1083,330
Minority interest4395
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,0732,7023,1083,330
Inc. avail. to common incl. extra. items3,0732,7023,1083,330
Diluted net income3,0732,7023,1083,330
Dilution adjustment0000
Diluted weighted average shares1,3171,3201,3251,339
Diluted EPS excluding extraordinary itemsvalue per share2.332.052.352.49
Dividends per sharevalue per share0.520.520.470.47
Diluted normalized EPSvalue per share2.332.052.352.49